The use of [2-C 6 R 4 PPh 2 ] − (R = H, F) and related carbanions as building blocks in coordination chemistry

Experimental and Computational Studies of Ruthenium Complexes Bearing Z-Acceptor Aluminum-Based Phosphine Pincer Ligands

Reaction of [Ru(C₆H₄PPh₂)₂(Ph₂PC₆H₄AlMe(THF))H] with CO results in clean conversion to the Ru-Al heterobimetallic complex [Ru(AlMePhos)(CO)₃] (1), where AlMePhos is the novel P-Al(Me)-P pincer ligand (o-Ph₂PC₆H₄)₂AlMe. Under photolytic conditions, 1 reacts with H₂ to give [Ru(AlMePhos)(CO)₂(μ-H)H] (2) that is characterized by multinuclear NMR and IR spectroscopies. DFT calculations indicate that 2 features one terminal and one bridging hydride that are respectively anti and syn to the AlMe group. Calculations also define a mechanism for H₂ addition to 1 and predict facile hydride exchange in 2 that is also observed experimentally. Reaction of 1 with B(C₆F₅)₃ results in Me abstraction to form the ion pair [Ru(AlPhos)(CO)₃][MeB(C₆F₅)₃] (4) featuring a cationic [(o-Ph₂PC₆H₄)₂Al]⁺ ligand, [AlPhos]⁺. The Ru-Al distance in 4 (2.5334(16) Å) is significantly shorter than that in 1 (2.6578(6) Å), consistent with an enhanced Lewis acidity of the [AlPhos]⁺ ligand. This is corroborated by a blue shift in both the observed and computed ν_CO stretching frequencies upon Me abstraction. Electronic structure analyses (QTAIM and EDA-ETS) comparing 1, 4, and the previously reported [Ru(ZnPhos)(CO)₃] analogue (ZnPhos = (o-Ph₂PC₆H₄)₂Zn) indicate that the Lewis acidity of these pincer ligands increases along the series ZnPhos < AlMePhos < [AlPhos]⁺.

Nickel and Palladium Complexes of a PP(O)P Pincer Ligand Based upon a peri-Substituted Acenaphthyl Scaffold and a Secondary Phosphine Oxide

A PP(O)P pincer ligand based upon a peri-substituted acenaphthyl (Ace) scaffold and a secondary phosphine oxide, (5-Ph₂P-Ace-6-)₂P(O)H, was prepared and fully characterized including a neutron diffraction study. The reaction with [Ni(H₂O)₆]Cl₂ and PdCl₂ produced ionic metal(II) complexes [κ³-P,P',P''((5-Ph₂P-Ace-6-)₂P(OH))MCl]Cl, which upon addition of Et₃N gave rise to zwitterionic metal(II) complexes κ³-P,P',P''((5-Ph₂P-Ace-6-)₂P(O))MCl (M = Ni, Pd). The reaction with Ni(COD)₂ (COD = cyclooctadiene) provided the η³-cyclooctenyl Ni(II) complex κ³-P,P',P''((5-Ph₂P-Ace-6-)₂P(O))Ni(η³-C₈H₁₃). A detailed complementary bonding analysis of the P-H, P-O, and P-M interactions was carried out (M = Ni, Pd).

Facile Synthesis and Utilization of Bis(o-phosphinophenyl)zinc as Isolable PZnP-pincer Ligands Enabled by Boron-Zinc Double Transmetallation

Bis(o-phosphinophenyl)zinc derivatives were successfully synthesized by the reaction of o-phosphinophenylboronates with dimethylzinc via boron-zinc double transmetallation. The transmetallation was significantly accelerated by the presence of the ortho PR2 substituent to...

Dinuclear orthometallated gold(I)-gold(III) anticancer complexes with potent in vivo activity through an ROS-dependent mechanism

Increasingly explored over the last decade, gold complexes have shown great promise in the field of cancer therapeutics. A major obstacle to their clinical progression has been their lack of in vivo stability, particularly for gold(III) complexes, which often undergo a facile reduction in the presence of biomolecules such as glutathione. Herein, we report a new class of promising anticancer gold(I)-gold(III) complexes with the general formula [XAuI(μ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuIIIX] [X = Cl (1), Br (2), NO3 (3)] which feature two gold atoms in different oxidation states (I and III) in a single molecule. Interestingly, gold(I)-gold(III) complexes (1-3) are stable against glutathione reduction under physiological-like conditions. In addition, complexes 1-3 exhibit significant cytotoxicity (276-fold greater than cisplatin) toward the tested cancer cells compared to the noncancerous cells. Moreover, the gold(I)-gold(III) complexes do not interact with DNA-like cisplatin but target cellular thioredoxin reductase, an enzyme linked to the development of cisplatin drug resistance. Complexes 1-3 also showed potential to inhibit cancer and endothelial cell migration, as well as tube formation during angiogenesis. In vivo studies in a murine HeLa xenograft model further showed the gold compounds may inhibit tumor growth on par clinically used cisplatin, supporting the significant potential this new compound class has for further development as cancer therapeutic.

Impact of the Novel Z-Acceptor Ligand Bis{(ortho-diphenylphosphino)phenyl}zinc (ZnPhos) on the Formation and Reactivity of Low-Coordinate Ru(0) Centers

The preparation and reactivity with H₂ of two Ru complexes of the novel ZnPhos ligand (ZnPhos = Zn(o-C₆H₄PPh₂)₂) are described. Ru(ZnPhos)(CO)₃ (2) and Ru(ZnPhos)(IMe₄)₂ (4; IMe₄ = 1,3,4,5-tetramethylimidazol-2-ylidene) are formed directly from the reaction of Ru(PPh₃)(C₆H₄PPh₂)₂(ZnMe)₂ (1) or Ru(PPh₃)₃HCl/LiCH₂TMS/ZnMe₂ with CO and IMe₄, respectively. Structural and electronic structure analyses characterize both 2 and 4 as Ru(0) species in which Ru donates to the Z-type Zn center of the ZnPhos ligand; in 2, Ru adopts an octahedral coordination, while 4 displays square-pyramidal coordination with Zn in the axial position. Under photolytic conditions, 2 loses CO to give Ru(ZnPhos)(CO)₂ that then adds H₂ over the Ru-Zn bond to form Ru(ZnPhos)(CO)₂(μ-H)₂ (3). In contrast, 4 reacts directly with H₂ to set up an equilibrium with Ru(ZnPhos)(IMe₄)₂H₂ (5), the product of oxidative addition at the Ru center. DFT calculations rationalize these different outcomes in terms of the energies of the square-pyramidal Ru(ZnPhos)L₂ intermediates in which Zn sits in a basal site: for L = CO, this is readily accessed and allows H₂ to add across the Ru-Zn bond, but for L = IMe₄, this species is kinetically inaccessible and reaction can only occur at the Ru center. This difference is related to the strong π-acceptor ability of CO compared to IMe₄. Steric effects associated with the larger IMe₄ ligands are not significant. Species 4 can be considered as a Ru(0)L₄ species that is stabilized by the Ru→Zn interaction. As such, it is a rare example of a stable Ru(0)L₄ species devoid of strong π-acceptor ligands.

Ruthenium Complexes of Stibino Derivatives of Carboxylic Amides: Synthesis and Characterization of Bidentate Sb,E, Tridentate Sb,E2, and Tetradentate Sb,E3 (E = N and O) Ligands and Their Reactivity Toward [RuCl2(PPh3)3]

Neutral bi-, tri-, and tetradentate ligands of the type Ph_3-xSb(L)_x [x = 1 (1), 2 (2), and 3 (3). L = La = phthalimidinyl (1a, 2a, and 3a), Lb = 2-pyridyloxy (1b, 2b, and 3b)] have been synthesized and characterized. Reaction of the Sb,E and Sb,E₂ ligands with [RuCl₂(PPh₃)₃] proceeded under anion scrambling with formation of complexes of type [Ph₂Sb(μ-L)₂Ru(PPh₃)(μ-Cl)]₂ (5) or [PhSb(μ-L)₃RuCl(PPh₃)] (8) in addition to various byproducts. Reactions of the Sb,E₃ ligands and [RuCl₂(PPh₃)₃] afforded highly diverse product mixtures. Deliberate syntheses of complexes of types 5 and 8 were successful by supplementing the reaction mixture with the required stoichiometric amount of either HLa or HLb and a supporting base. The Sb-Ru bonds, which are bridged by two (type 5) or three (type 8) phthalimidinyl or 2-pyridyloxy ligands, have been investigated using quantum chemical calculations at the DFT level (NBO/NLMO and AIM). Treatment of complexes of type 8 with fluoride ions resulted in the formation of compounds of type [PhFSb(μ-La)₃RuL'(PPh₃)] (L' = O₂ (9a-O₂), NCMe (9a-NCMe), or [PhFSb(μ-Lb)₂Ru(κ²-Lb)(PPh₃)] (10b)). In contrast to other similar bimetallic Sb-TM complexes (TM = transition metal), which may switch the rather dative intermetallic bond from Sb→TM to Sb←TM upon replacing TM bound chloride by Sb-bound fluoride, the character of the Sb→Ru bond is essentially retained upon going from chloro complex 5 or 8 to fluoro complex 9 or 10. Charge discrepancies caused by anion transfer from Ru to Sb are mainly compensated for by charge flow along the ligand backbone. All isolated complexes were characterized with multinuclear NMR spectroscopy, single-crystal X-ray diffraction, elemental analysis, and quantum chemical calculations.